Transcription of RADIOPHARMACEUTICALS - WHO
{{id}} {{{paragraph}}}
Document November 2008 RADIOPHARMACEUTICALS Final text for addition to T he International Pharm acopoeia (November 2008) This text was adopted at the Forty-third WHO Expert Committee on Specifications for Pharmaceutical Preparations in October 2008 for addition to the 4th edition of The International Pharmacopoeia. Contents Introduction Monographs General monograph Specific monographs Methods of Analysis Supplementary Information Introduction RADIOPHARMACEUTICALS are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. The facilities and procedures for the production, use, and storage of RADIOPHARMACEUTICALS are subject to licensing by national and/or regional authorities.
Document QAS/08.262/FINAL November 2008 RADIOPHARMACEUTICALS Final text for addition to The International Pharmacopoeia (November 2008) This text was adopted at the Forty-third WHO Expert Committee on Specifications for
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
IAEA Safety Standards, IAEA SAFETY STANDARDS SERIES, Safety, IAEA Safety, CATEGORIES IN THE IAEA SAFETY SERIES, In the IAEA Safety Series, Management System and Quality Assurance, Management System and Quality Assurance Standards for Nuclear, IAEA, Nuclear Security Legal and Regulatory Framework, Standards, Report WENRA Safety Reference Levels for, Report WENRA Safety Reference Levels for Existing Reactors, NATIONAL NUCLEAR REGULATOR, 1986-2016: CHERNOBYL at 30 An update